C86.60 Abrechenbarer, spezifischer Code Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
ICD-10-CM C86.60 identifies “Primary cutaneous CD30-positive T-cell proliferations not having achieved remission” as a billable/specific code in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Kapitel 2: Neoplasms
Hinweise zum Code
Inclusion terms11
- Lymphomatoid papulosis NOS
- Lymphomatoid papulosis not having achieved remission
- Lymphomatoid papulosis with failed remission
- Primary cutaneous anaplastic large cell lymphoma NOS
- Primary cutaneous anaplastic large cell lymphoma not having achieved remission
- Primary cutaneous anaplastic large cell lymphoma with failed remission
- Primary cutaneous CD30-positive large T-cell lymphoma NOS
- Primary cutaneous CD30-positive large T-cell lymphoma not having achieved remission
- Primary cutaneous CD30-positive large T-cell lymphoma with failed remission
- Primary cutaneous CD30-positive T-cell proliferations NOS
- Primary cutaneous CD30-positive T-cell proliferations with failed remission
Hinweise übergeordneter Ebenen
Kapitel 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
C86 · Other specified types of T/NK-cell lymphoma
C86.6 · Primary cutaneous CD30-positive T-cell proliferations
Inclusion terms3
- Lymphomatoid papulosis
- Primary cutaneous anaplastic large cell lymphoma
- Primary cutaneous CD30-positive large T-cell lymphoma
Verweise im offiziellen Index
Offizielle Konversionshistorie
Historical assignments from the CDC conversion table support data retrieval. They do not authorize substituting a previous code for the current code.
Frühere Zuordnung: C86.6
Verweise anderer Codes (1)
Excludes 1 · primary cutaneous CD30-positive T-cell proliferations (C86.60)
Verlauf
Codeverlauf
Letzte erfasste Änderung · FY2025
Gültig ab
- Hinzugefügt
Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
Abrechenbarer Diagnosecode
CDC/NCHS · FY2025Alle Ausgaben (5)
| Alle Ausgaben | Gültig ab | Codeverlauf |
|---|---|---|
| FY2025 | 2024-10-01 | Hinzugefügt |
| FY2025 · 04-01 | 2025-04-01 | Keine tabellarische Änderung |
| FY2026 | 2025-10-01 | Keine tabellarische Änderung |
| FY2026 · April | 2026-04-01 | Keine tabellarische Änderung |
| FY2027 | 2026-10-01 | Keine tabellarische Änderung |
Dieser Eintrag ist ein vollständiger Code in der gewählten Ausgabe. Die Referenzprüfung bestätigt keine klinische Eignung und garantiert keine Erstattung.